Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • CLFougner
    Junior Member
    • Mar 2016
    • 2

    #1

    Compare mouse cancer sequence data with COSMIC database

    I'm working with whole exome sequence data from a mouse breast cancer model. I've done mutation calling using the GATK best practices workflow (BWA mem (mm10) -> Picard deduplicate -> base quality score recalibration -> Mutect2. Annotated .vcfs with SnpEff). I now wanted to compare my variants to the COSMIC data base to see if the orthologous variants have been found in human, and am having trouble figuring out the most appropriate way to do this.

    My first thought was to convert my VCF files to .bed files and use the UCSC liftover tool to convert the files from m10 to hg19. I've however also found a publication in which they perform what I'm looking to do, and in their methods they write:

    Variants were compared to known human somatic mutations as available via the COSMIC database38. Briefly, the mouse and human sequences for homologous proteins were pairwise aligned using Clustal Omega39 and the human protein position homolo- gous to the mouse mutation was used to query COSMIC for known missense and nonsense mutations at or surrounding this peptide position. Local conservation was determined after sequence alignment using a 6 10 amino acid residue window surrounding the substituted amino acid.
    I've looked into Clustal Omega, but I'm having trouble understanding how to implement it into this sort of workflow.

    I'm wondering if anyone has done this sort of analysis, and what workflow you've had the most success with?

    Thanks!
  • tristan dubos
    Member
    • Dec 2015
    • 39

    #2
    Hi ,
    I looked the Clustal Omega and you can only compared homologous by pair ? and the think is how to automatize it ?

    Trist

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 02:55 AM
    0 responses
    4 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Working...